Form D · Other Health Care
MedArrive Inc.
New York, NY · CIK 0001901894
Offering snapshot reported Apr 11, 2023 · SEC filing
- Reported sold
- $8M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 11, 2023 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Feb 11, 2022 | Initial | $32,843,775 | No comparison | 41 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-478441
Source: Form D, filed Apr 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Agneta Breitenstein | Director |
| Annie Case | Director |
| Andy Harrison | Director |
| Lynne Chou O'keefe | Director |
| Inna Plumb | Executive |
| William Sullivan | Director |
| Daniel Trigub | Director, Executive |
| Dan Trigub | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
85 5 Th Ave 8 Th Floor
New York, NY, 10003
New York, NY, 10003